immunique Venture Capital
1 known investors
Immunique develops a feeder-free NK cell production platform to generate consistent natural killer cells for post-cancer treatment recovery care, targeting long-term toxicity and functional decline in cancer patients.
BiotechDigital HealthMedical Devices